🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate a new questionnaire to capture the...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-29
Trial ID
NCT00984659
Treatments Being Tested
This retrospective database study will assess differences in the risk of re...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01381458
The purpose of this study is to assess whether the risk of serious asthma-r...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-17
Trial ID
NCT01462344
Treatments Being Tested
This trial is a randomized, double-blind, parallel-group, multicenter study...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04-30
Trial ID
NCT01110200
Treatments Being Tested
A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10-13
Trial ID
NCT02924688
This is a multi-centre, randomised, double-blind, double-dummy, two way cro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-14
Trial ID
NCT01978145
This study is to evaluate the utility of the PCL Rapid Antigen Test for Cor...
Status
Unknown
Location
Musgrove Park Hospital
Start Date
2020-06
Trial ID
NCT04403906
Treatments Being Tested
To evaluate COPD-related clinical outcomes and total healthcare utilization...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT01331694
Study title * A randomized, open label, multicenter, phase 4 study for the...
Status
Completed
Location
Soonchunhyang University Bucheon Hospital
Start Date
2009-03
Trial ID
NCT00864812
Treatments Being Tested
The purpose of this study was to determine whether asthma control and reduc...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-01
Trial ID
NCT01324362
Treatments Being Tested